Gara Michael A, Vega William A, Arndt Stephan, Escamilla Michael, Fleck David E, Lawson William B, Lesser Ira, Neighbors Harold W, Wilson Daniel R, Arnold Lesley M, Strakowski Stephen M
University of Medicine and Dentistry of New Jersey University Behavioral HealthCare and Robert Wood Johnson Medical School, Piscataway, NJ 08855, USA.
Arch Gen Psychiatry. 2012 Jun;69(6):593-600. doi: 10.1001/archgenpsychiatry.2011.2040.
Rates of clinical diagnoses of schizophrenia in African American individuals appear to be elevated compared with other ethnic groups in the United States, contradicting population rates derived from epidemiologic surveys.
To determine whether African American individuals would continue to exhibit significantly higher rates of clinical diagnoses of schizophrenia, even after controlling for age, sex, income, site, and education, as well as the presence or absence of serious affective disorder, as determined by experts blinded to race and ethnicity. A secondary objective was to determine if a similar pattern occurred in Latino subjects.
Ethnicity-blinded and -unblinded diagnostic assessments were obtained in 241 African American individuals (mean [SD] age, 34.3 [8.1] years; 57% women), 220 non-Latino white individuals (mean [SD] age, 32.7 [8.5] years; 53% women), and 149 Latino individuals (mean [SD] age, 33.5 [8.0] years; 58% women) at 6 US sites. Logistic regression models were used to determine whether elevated rates of schizophrenia in African American individuals would persist after controlling for various confounding variables including blinded expert consensus diagnoses of serious affective illness.
Six academic medical centers across the United States.
Six hundred ten psychiatric inpatients and outpatients.
Relative odds of unblinded clinical diagnoses of schizophrenia in African American compared with white individuals.
A significant ethnicity/race effect (χ(2)(2)=10.4, P=.01) was obtained when schizophrenia was narrowly defined, controlling for all other predictors. The odds ratio comparing African American with non-Latino white individuals was significant (odds ratio=2.7; 95% CI, 1.5-5.1). Similar differences between African American and white individuals occurred when schizophrenia was more broadly defined (odds ratio=2.5; 95% CI, 1.4-4.5). African American individuals did not differ significantly from white individuals in overall severity of manic and depressive symptoms but did evidence more severe psychosis.
African American individuals exhibited significantly higher rates of clinical diagnoses of schizophrenia than non-Latino white subjects, even after controlling for covariates such as serious affective disorder.
与美国其他种族群体相比,非裔美国人中精神分裂症的临床诊断率似乎更高,这与流行病学调查得出的总体发病率相矛盾。
确定即使在控制了年龄、性别、收入、地点、教育程度以及是否存在严重情感障碍(由对种族和民族不知情的专家确定)之后,非裔美国人中精神分裂症的临床诊断率是否仍会显著更高。第二个目的是确定拉丁裔受试者中是否也出现类似模式。
在美国6个地点对241名非裔美国人(平均[标准差]年龄,34.3[8.1]岁;57%为女性)、220名非拉丁裔白人(平均[标准差]年龄,32.7[8.5]岁;53%为女性)和149名拉丁裔(平均[标准差]年龄,33.5[8.0]岁;58%为女性)进行了不考虑种族和考虑种族的诊断评估。使用逻辑回归模型来确定在控制各种混杂变量(包括对严重情感疾病的不知情专家共识诊断)后,非裔美国人中精神分裂症的高诊断率是否会持续存在。
美国的六个学术医疗中心。
610名精神科住院患者和门诊患者。
非裔美国人与白人相比,未考虑种族的精神分裂症临床诊断的相对比值比。
在狭义定义精神分裂症并控制所有其他预测因素时,获得了显著的种族/民族效应(χ(2)(2)=10.4,P=.01)。非裔美国人与非拉丁裔白人个体的比值比显著(比值比=2.7;95%置信区间,1.5 - 5.1)。当更广泛地定义精神分裂症时,非裔美国人和白人个体之间也出现了类似差异(比值比=2.5;95%置信区间,1.4 - 4.5)。非裔美国人在躁狂和抑郁症状的总体严重程度上与白人个体没有显著差异,但确实表现出更严重的精神病症状。
即使在控制了严重情感障碍等协变量之后,非裔美国人中精神分裂症的临床诊断率仍显著高于非拉丁裔白人受试者。